Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Retrovir
Zidovudine, also known as AZT, ZDV and azidothymidine, is an antiretroviral agent used for treatment of HIV infection in combination with at least two other antiretroviral agents. As a monotherapy it is used for the prevention of maternal/fetal HIV transmission.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| HIV (Human Immunodeficiency Virus) | 24 | 7 |
|
|
|
||
| Don't know | 1 | 0 | |||||
| Participate in clinical trial | 1 | 1 |
|
||||
| Chronic Fatigue Syndrome | 1 | 1 |
|
||||
| XMRV infection | 1 | 0 |
See all 19 patients currently taking Zidovudine (AZT/ZDV/Azidothymidine)
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Zidovudine (AZT/ZDV/Azidothymidine)
| Nausea | 2 | |
|---|---|---|
| Dizziness | 2 | |
| Anemia | 2 | |
| Lipodystrophy (lipoatrophy or loss of fatty tissue) | 1 | |
| Vomiting | 1 | |
| Iron Deficiency Anemia | 1 |
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 9 | ||
| Side effects too severe | 7 | ||
| Did not seem to work | 2 | ||
| Other | 2 | ||
| Personal research | 1 | ||
| Course of treatment ended | 1 |
See all 16 patients who’ve stopped taking Zidovudine (AZT/ZDV/Azidothymidine)
Adherence
Taking treatment as prescribed
Adherence of Zidovudine (AZT/ZDV/Azidothymidine)
Always |
5 | 56% |
|
|---|---|---|---|
Usually |
2 | 22% |
|
Sometimes |
1 | 11% |
|
Never |
1 | 11% |
|
Burden
Difficulty being on treatment
Burden of Zidovudine (AZT/ZDV/Azidothymidine)
Very |
3 | 33% |
|
|---|---|---|---|
Somewhat |
2 | 22% |
|
A little |
0 | 0% |
|
Not at all |
4 | 44% |
|
Cost
Paid out of pocket
Cost of Zidovudine (AZT/ZDV/Azidothymidine)
$200+ |
1 | 14% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
5 | 71% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.